We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

SLAB:NASDAQSilicon Laboratories, Inc. Analysis

Data as of 2026-05-01 - not real-time

$217.70

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

Silicon Laboratories is trading at $217.70, comfortably above its 20‑day (212.9) and 50‑day (208.1) moving averages, indicating a short‑term bullish bias, but the RSI of 83 signals an overbought condition and the price is flirting with the near‑term resistance of $217.94. Technical momentum remains positive with a bullish MACD crossover, yet the histogram is marginal (0.014) and volume is only modestly increasing, suggesting limited upside momentum. Valuation metrics are stretched – the forward PE sits at 52.5, price‑to‑book is 6.6, and the DCF‑derived fair value of $98.99 is well below the current market price, flagging the stock as overvalued.
On the fundamentals side, SLAB posted a 25% revenue surge to $784 M and maintains a solid 58% gross margin, but operating and net margins remain negative (‑1.6% and ‑8.3% respectively) with a trailing EPS of –$1.98. The balance sheet is strong, featuring $443 M in cash against modest debt of $24 M, and the company is expanding its IoT and wireless portfolio, highlighted by recent in‑tire sensor platform announcements. While the sector enjoys long‑term tailwinds, the combination of high valuation, profitability challenges, and a beta of ~1.3 points to elevated risk despite the current “Extreme Greed” market sentiment.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • RSI in overbought territory
  • Price at near‑term resistance
  • Negative earnings and high forward PE

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Strong revenue growth and expanding IoT product line
  • Robust cash position with low debt
  • Increasing volume and bullish MACD signal

Long Term

> 3 years
Neutral
Model confidence: 5/10

Key Factors

  • Long‑term semiconductor and IoT tailwinds
  • Need to turn operating profit to justify valuation
  • Current overvaluation relative to DCF fair value

Key Metrics & Analysis

Financial Health

Revenue Growth25.20%
Profit Margin-8.27%
P/E Ratio52.5
ROE-5.97%
ROA-3.54%
Debt/Equity2.19
P/B Ratio6.6
Op. Cash Flow$95.7M
Free Cash Flow$78.1M
Industry P/E37.9

Technical Analysis

TrendBullish
RSI83.1
Support$206.64
Resistance$217.94
MA 20$212.92
MA 50$208.10
MA 200$156.71
MACDBullish
VolumeIncreasing
Fear & Greed Index90.93

Valuation

Fair Value$98.99
Target Price$222.86
Upside/Downside2.37%
GradeOvervalued
TypeGrowth

Risk Assessment

Beta1.26
Volatility4.99%
Sector RiskHigh
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.